141 related articles for article (PubMed ID: 32359831)
1. Epidemiology of Cholangiocarcinoma; United States Incidence and Mortality Trends.
Gad MM; Saad AM; Faisaluddin M; Gaman MA; Ruhban IA; Jazieh KA; Al-Husseini MJ; Simons-Linares CR; Sonbol MB; Estfan BN
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):885-893. PubMed ID: 32359831
[TBL] [Abstract][Full Text] [Related]
2. Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.
Wang J; Li E; Yang H; Wu J; Lu HC; Yi C; Lei J; Liao W; Wu L
World J Surg Oncol; 2019 Feb; 17(1):43. PubMed ID: 30813932
[TBL] [Abstract][Full Text] [Related]
3. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.
Antwi SO; Mousa OY; Patel T
Ann Hepatol; 2018 July - August ,; 17(4):604-614. PubMed ID: 29893702
[TBL] [Abstract][Full Text] [Related]
4. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
Welzel TM; McGlynn KA; Hsing AW; O'Brien TR; Pfeiffer RM
J Natl Cancer Inst; 2006 Jun; 98(12):873-5. PubMed ID: 16788161
[TBL] [Abstract][Full Text] [Related]
5. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
Saha SK; Zhu AX; Fuchs CS; Brooks GA
Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
[TBL] [Abstract][Full Text] [Related]
6. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.
Patel T
Hepatology; 2001 Jun; 33(6):1353-7. PubMed ID: 11391522
[TBL] [Abstract][Full Text] [Related]
7. Have incidence rates of liver cancer peaked in the United States?
Petrick JL; Florio AA; Loomba R; McGlynn KA
Cancer; 2020 Jul; 126(13):3151-3155. PubMed ID: 32294255
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.
Koshiol J; Yu B; Kabadi SM; Baria K; Shroff RT
BMC Cancer; 2022 Nov; 22(1):1178. PubMed ID: 36384474
[TBL] [Abstract][Full Text] [Related]
9. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
Van Dyke AL; Shiels MS; Jones GS; Pfeiffer RM; Petrick JL; Beebe-Dimmer JL; Koshiol J
Cancer; 2019 May; 125(9):1489-1498. PubMed ID: 30645774
[TBL] [Abstract][Full Text] [Related]
10. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
[No Abstract] [Full Text] [Related]
11. Trends in the Mortality of Biliary Tract Cancers Based on Their Anatomical Site in the United States From 2009 to 2018.
Kim D; Konyn P; Cholankeril G; Bonham CA; Ahmed A
Am J Gastroenterol; 2021 May; 116(5):1053-1062. PubMed ID: 33929380
[TBL] [Abstract][Full Text] [Related]
12. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB
J Hepatol; 2012 Apr; 56(4):848-54. PubMed ID: 22173164
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis.
Newsome JR; Venkatramani R; Heczey A; Danysh HE; Fishman DS; Miloh T
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):e12-e18. PubMed ID: 28937543
[TBL] [Abstract][Full Text] [Related]
14. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
McGlynn KA; Tarone RE; El-Serag HB
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1198-203. PubMed ID: 16775181
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
[TBL] [Abstract][Full Text] [Related]
16. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification.
Tyson GL; Ilyas JA; Duan Z; Green LK; Younes M; El-Serag HB; Davila JA
Dig Dis Sci; 2014 Dec; 59(12):3103-10. PubMed ID: 25204668
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma: a pan-Pacific perspective.
Desmond MK; Wong LL
Am Surg; 2015 Apr; 81(4):E181-3. PubMed ID: 25831173
[No Abstract] [Full Text] [Related]
18. The epidemiology of cholangiocarcinoma.
Shaib Y; El-Serag HB
Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.
Shaib YH; El-Serag HB; Davila JA; Morgan R; McGlynn KA
Gastroenterology; 2005 Mar; 128(3):620-6. PubMed ID: 15765398
[TBL] [Abstract][Full Text] [Related]
20. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
